TickerKhojComparison · NSE · data 2026-11-03
Ind-Swift Laboratories Ltd. vs Solara Active Pharma Sciences Ltd.
In plain words
Size: Ind-Swift Laboratories Ltd. is about 1 times the market value of Solara Active Pharma Sciences Ltd..
Valuation (P/E): Solara Active Pharma Sciences Ltd. 83.8 vs Ind-Swift Laboratories Ltd. 35.6.
Return on equity: Ind-Swift Laboratories Ltd. 3.4% vs Solara Active Pharma Sciences Ltd. -0.6%.
Debt to equity: Solara Active Pharma Sciences Ltd. 0.55 vs Ind-Swift Laboratories Ltd. 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| INDSWFTLAB | SOLARA | |
|---|---|---|
| Price | ₹343.75 | ₹629.75 |
| Market cap | ₹3,080 cr | ₹3,061 cr |
| P/E | 35.6 | 83.8 |
| P/B | 2 | 2.1 |
| ROE | 3.4% | -0.6% |
| ROCE | -0.2% | 5.9% |
| Debt / equity | 0.01 | 0.55 |
| Operating margin | 9.4% | 8.4% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | -19.6% | -1.6% |
| Profit growth, 3 years (yearly) | -3.2% | — |
| 1-year return | 234.7% | 4.4% |
| Revenue, last 12 months | ₹753 cr | ₹1,535 cr |
| Net profit, last 12 months | ₹84 cr | ₹37 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹34 cr | ₹28 cr |
| Quarter profit vs a year earlier | +328.3% | — |
| Promoter holding | 42.93% | 41.93% |
| Health check | Average (5.7/10) | Weak (2.5/10) |
Common questions
Which has a higher P/E, Ind-Swift Laboratories Ltd. or Solara Active Pharma Sciences Ltd.?
Solara Active Pharma Sciences Ltd. trades at the higher P/E (83.8 against 35.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Ind-Swift Laboratories Ltd. (3.4% against -0.6%).
Which carries more debt?
Solara Active Pharma Sciences Ltd. has the higher debt-to-equity ratio (0.55 against 0.01).